Medtronic: Patent Enforcement will Kill Patients

By Dennis Crouch Edwards Life Scoence v. CoreValve and Medtronic (Fed. Cir. 2014) In an emergency motion, Medtronic has asked the Federal Circuit to stay a preliminary injunction blocking sale of the Medtronic’s CoreValve aortic heart valve replacement system. Delaware district court Chief Judge Gregory Sleet ordered the preliminary injunction and would enforce the injunction […]
Read the full story here: Patently-O » Patent

Court Report

By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Novartis Pharmaceuticals Corp. et al. v. Dr. Reddy’s Laboratories Ltd. et al. 1:14-cv-00387; filed March 26, 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG • Defendants: Dr. Reddy’s Laboratories Ltd.; Dr. Reddy’s Laboratories Inc. Infringement of U.S. Patent No. RE43,932 (“Crystal Modification of a N-phenyl-2-pyrimidineamine Derivative, Processes for Its Manufacture and Its Use,” issued January 15, 2013) following a Paragraph IV certification as part of Dr. Reddy’s filing of an ANDA to manufacture a…
Read the full story here: Patent Docs

Webinar on International Trade Secret Misappropriation

McDonnell Boehnen Hulbert & Berghoff LLP will be offering a live webinar entitled “International Trade Secret Misappropriation Update 2014″ on April 22, 2014 from 10:00 am to 11:15 am (CT). MBHB attorney Joshua R. Rich will address the steps that have been taken (and those recently undertaken) to combat international trade secret misappropriation. The webinar will address the following topics: • Federal and State legislative enactments and proposals • The Federal Joint Strategic Plan on Intellectual Property Enforcement • Private and public proposals for limiting trade secret misappropriation • Recent developments in criminal enforcement of trade secret rights While there…
Read the full story here: Patent Docs

Trolling Shot Down

To extort license revenue, DataTern sued only the customers of Microsoft and
SAP database products for patent infringement (5,937,402
&

6,101,502). Microsoft and SAP and were let alone. But, in response to
customer complaints about DataTern, those two software giants filed a DJ against
DataTern’s assertion. DataTern argued lack of subject matter jurisdiction, to no
avail. The fix was in. Summary judgment of noninfringement for all claims of the
patents, upheld on appeal. The district court had allowed that to apply to all
SAP products, but the CAFC (2013-1184)
pared that back to the single product in dispute.

Read the full story here: Patent Prospector

ACI Biosimilars Conference

American Conference Institute (ACI) will be holding a conference on Biosimilars on June 4-6, 2014 in New York, NY. ACI faculty will help attendees: • Understand the battles over naming and substitution on the federal and state levels and exploring the implications on competition including the FTC’s current perspective; • Analyzing the arguments in the first BPCIA case, Sandoz Inc. v. Amgen Inc., and preparing now for the strict litigation timelines once the first applications are filed; • Integrating the monumental changes under the AIA including inter partes review and post-grant review into your biosimilars prosecution and litigation strategies; •…
Read the full story here: Patent Docs

Get Adobe Flash playerPlugin by wpburn.com wordpress themes